VAERS reports by lot

Moderna COVID-19 lot AU3914B: VAERS reports

52 VAERS reports list lot AU3914B as a Moderna COVID-19 vaccine, received between 2023-10-14 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
52
Reports
2%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1018%
Injection-site / Local reaction1018%
Neurological916%
Cardiac / Cardiovascular916%
Respiratory611%
Musculoskeletal59%
Allergic / Anaphylactic35%
Dermatological (non-injection-site)35%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas32
California4
Washington2
Oregon2
Utah2
Kansas1
Massachusetts1
Kentucky1
Colorado1
New York1
Connecticut1
Alaska1

Reports by month received

2023-106
2023-119
2023-122
2024-0132
2024-042
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.